Scott E. Eggener to 5-alpha Reductase Inhibitors
This is a "connection" page, showing publications Scott E. Eggener has written about 5-alpha Reductase Inhibitors.
Connection Strength
0.565
-
Editorial comment on: Pharmacological approaches to reducing the risk of prostate cancer. Eur Urol. 2009 May; 55(5):1073-4.
Score: 0.329
-
Hormonal Therapy and Radiation Therapy in Prostate Cancer: 5-Year Outcomes From a Trial Evaluating Combined Androgen Blockade With 5-Alpha Reductase Inhibitors as an Alternative to Gonadotropin Releasing Hormone Agonists. Clin Genitourin Cancer. 2024 Aug; 22(4):102103.
Score: 0.236